Oncology & Cancer

Benefit of PET or PET/CT in recurrent bowel cancer is not proven

For patients in whom a recurrence of bowel cancer is suspected, the study data currently available allow no robust conclusions as to the advantages and disadvantages of using positron emission tomography (PET), alone or in ...

Oncology & Cancer

New animal models can revolutionize the study of cancer

Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug against ovarian ...

Oncology & Cancer

Potential new colorectal cancer treatment target identified

(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research ...

page 3 from 4